Dr. James McNamara is a researcher in the Heart Disease and Regeneration Group at The Murdoch Children’s Research Institute. His research has focused on molecular mechanisms of hypertrophic cardiomyopathy, a common form of genetic heart disease. This research led to the discovery that mutations linked to hypertrophic cardiomyopathy increased the number of active myosin motors in mouse and human hearts, providing a mechanism for how these mutations impair contraction, relaxation, and energy utilisation. He received his PhD in Medicine from the University of Sydney in 2017. He then undertook undertake postdoctoral training at the University of Cincinnati, supported by an American Heart Association Postdoctoral Fellowship for this period and continued to focus on the function of MYBPC3, establishing a mechanism for its role in adrenergic signaling in the heart. In 2020 he joined Prof. Enzo Porrello and A/Prof David Elliott’s groups at MCRI. Here, he continues to study molecular mechanisms of genetic heart diseases, now utilising human pluripotent stem cells as a human model of disease. James’ research is currently supported by multiple early career fellowships.
Dr. James McNamara is a researcher in the Heart Disease and Regeneration Group at The Murdoch Children’s Research Institute. His research has focused on molecular mechanisms of hypertrophic cardiomyopathy, a common form of genetic heart disease. ...
Dr. James McNamara is a researcher in the Heart Disease and Regeneration Group at The Murdoch Children’s Research Institute. His research has focused on molecular mechanisms of hypertrophic cardiomyopathy, a common form of genetic heart disease. This research led to the discovery that mutations linked to hypertrophic cardiomyopathy increased the number of active myosin motors in mouse and human hearts, providing a mechanism for how these mutations impair contraction, relaxation, and energy utilisation. He received his PhD in Medicine from the University of Sydney in 2017. He then undertook undertake postdoctoral training at the University of Cincinnati, supported by an American Heart Association Postdoctoral Fellowship for this period and continued to focus on the function of MYBPC3, establishing a mechanism for its role in adrenergic signaling in the heart. In 2020 he joined Prof. Enzo Porrello and A/Prof David Elliott’s groups at MCRI. Here, he continues to study molecular mechanisms of genetic heart diseases, now utilising human pluripotent stem cells as a human model of disease. James’ research is currently supported by multiple early career fellowships.
Top Publications
Lipps, C, Yogeswaran, A, McNamara, J, Wilhelm, J, Truschel, T, Aslam, M, Reischauer, S, Voss, S, Keller, T, Doerr, O, et al.
C0-C1f region of cardiac myosin binding protein-C induces pro-inflammatory responses in fibroblasts.
European Heart Journal
42(Supplement_1)
:
ehab724.3246
2021
view publication
Singh, RR, McNamara, JW, Sadayappan, S.
Mutations in myosin S2 alter cardiac myosin-binding protein-C interaction in hypertrophic cardiomyopathy in a phosphorylation-dependent manner.
Journal of Biological Chemistry
297(1)
:
100836
2021
view publication
Lynch, TL, Kumar, M, McNamara, JW, Kuster, DWD, Sivaguru, M, Singh, RR, Previs, MJ, Lee, KH, Kuffel, G, Zilliox, MJ, et al.
Amino terminus of cardiac myosin binding protein-C regulates cardiac contractility.
Journal of Molecular and Cellular Cardiology
156:
33 -44
2021
view publication
Yogeswaran, A, Troidl, C, McNamara, JW, Wilhelm, J, Truschel, T, Widmann, L, Aslam, M, Hamm, CW, Sadayappan, S, Lipps, C.
The C0-C1f Region of Cardiac Myosin Binding Protein-C Induces Pro-Inflammatory Responses in Fibroblasts via TLR4 Signaling..
Cells
10(6)
:
2021
view publication
McNamara, JW, Porrello, ER.
From Fragrances to Heart Regeneration.
Circulation
143(20)
:
1987 -1990
2021
view publication